We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MRC Technology, AstraZeneca Collaborate

News   Jun 16, 2016

 
MRC Technology, AstraZeneca Collaborate
 
 
 

RELATED ARTICLES

Patient-specific Organoid Models Appendix Cancer Treatment

News

Patient-specific tumor ‘organoid’ models have been developed, to identify the most effective treatment for each tumor.

READ MORE

A Way to Visualize a Genetic Mutation

News

A team of scientists has developed a method that yields, for the first time, visualization of a gene amplifications and deletions known as copy number variants in single cells.

READ MORE

Compound Blocks Common Genetic Cause of ALS & Frontotemporal Dementia

News

Writing in the journal Cell Chemical Biology, Scripps Research chemist Matthew Disney, PhD, and colleagues describe a new compound that blocks the most common genetic cause of both familial ALS and frontotemporal dementia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE